<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30296717</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>20</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1879-2472</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>171</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                    </PubDate>                </JournalIssue>                <Title>Thrombosis research</Title>                <ISOAbbreviation>Thromb. Res.</ISOAbbreviation>            </Journal>            <ArticleTitle>Venous thrombosis and breast cancer in older women: Racial differences in risk factors and mortality.</ArticleTitle>            <Pagination>                <MedlinePgn>130-135</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0049-3848(18)30556-5</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.thromres.2018.10.002</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Risk factors for venous thromboembolism (VTE) in women with breast cancer are not known by race.</AbstractText>                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The purpose of our study was to determine risk factors for VTE and VTE associated mortality in white and black women with breast cancer.</AbstractText>                <AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">The SEER-Medicare merged database (2000 to 2011) was used for women 65 years and older diagnosed with breast cancer. Stratified by race, logistic regression was used to examine risk factors for VTE and Cox proportional hazards regression was used to evaluate the effect of VTE on mortality.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 276,028 women 65 years and older with breast cancer. Of those, 6.4% white and 10.1% black women with breast cancer had a diagnosis of VTE. In adjusted analyses by race, risk of VTE increased with each year of age in both white and black cohorts. VTE was independently associated with distant metastasis and coexisting medical conditions in white women and in black women, hypertension, heart failure and hyperlipidemia were determinants of VTE. VTE was not associated with distant metastasis in black women. Tumor size, grade, and receptor status were also not independently associated with VTE risk in either white or black women. VTE accorded a higher risk of death in both white (HR = 1.49, 95% CI, 1.34-1.65) and black women (HR = 1.57, 95% CI, 1.23-2.00) with breast cancer.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The study identified VTE risk factors and effect of VTE on mortality in white and black older women with breast cancer.</AbstractText>                <CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Faiz</LastName>                    <ForeName>A S</ForeName>                    <Initials>AS</Initials>                    <AffiliationInfo>                        <Affiliation>Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA. Electronic address: faizas@rutgers.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Guo</LastName>                    <ForeName>S</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kaveney</LastName>                    <ForeName>A</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Philipp</LastName>                    <ForeName>C S</ForeName>                    <Initials>CS</Initials>                    <AffiliationInfo>                        <Affiliation>Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>03</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Thromb Res</MedlineTA>            <NlmUniqueID>0326377</NlmUniqueID>            <ISSNLinking>0049-3848</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Deep vein thrombosis</Keyword>            <Keyword MajorTopicYN="N">Pulmonary embolism</Keyword>            <Keyword MajorTopicYN="N">Racial differences</Keyword>            <Keyword MajorTopicYN="N">Venous thromboembolism</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>07</Month>                <Day>19</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>09</Month>                <Day>21</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>9</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>9</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>9</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30296717</ArticleId>            <ArticleId IdType="pii">S0049-3848(18)30556-5</ArticleId>            <ArticleId IdType="doi">10.1016/j.thromres.2018.10.002</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>